Exchange: NASDAQ·Updated 12:22 PM EDT
MREO logo

MREOMereo Biopharma

$0.3249
$0.0155
(5.01%)
Today
EarningsAug 11
Mkt Cap$49.39M
Vol864,753.00
45

Neutral Sentiment

How do you feel about MREO?

About

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
39

Frequently Asked Questions

What is Market Cap of Mereo Biopharma Group Plc - ADR?
What is the 52-week high for Mereo Biopharma Group Plc - ADR?
What is the 52-week low for Mereo Biopharma Group Plc - ADR?
What is Mereo Biopharma Group Plc - ADR stock price today?
What was Mereo Biopharma Group Plc - ADR stock price yesterday?
What is the PE ratio of Mereo Biopharma Group Plc - ADR?
What is the Price-to-Book ratio of Mereo Biopharma Group Plc - ADR?
What is the 50-day moving average of Mereo Biopharma Group Plc - ADR?
How many employees does Mereo Biopharma Group Plc - ADR have?

Advertisement|Remove ads.